Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
17.02
-0.03 (-0.18%)
Aug 26, 2026, 4:00 PM EDT - Market closed
Contineum Therapeutics Employees
Contineum Therapeutics had 51 employees as of December 31, 2025. The number of employees increased by 10 or 24.39% compared to the previous year.
Employees
51
Change (1Y)
10
Growth (1Y)
24.39%
Revenue / Employee
n/a
Profits / Employee
-$1,128,588
Market Cap
640.31M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 51 | 10 | 24.39% |
| Dec 31, 2024 | 41 | 10 | 32.26% |
| Dec 31, 2023 | 31 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MiMedx Group | 808 |
| Autolus Therapeutics | 754 |
| Valneva SE | 620 |
| Arvinas | 246 |
| CorMedix | 191 |
| Prime Medicine | 146 |
| Verastem | 102 |
| OmniAb | 89 |
CTNM News
- 1 day ago - Contineum Therapeutics to Present at the 2026 Morgan Stanley Global Healthcare Conference - Business Wire
- 26 days ago - Contineum initiated with an Outperform at LifeSci Capital - TheFly
- 27 days ago - Contineum reports Q2 EPS (40c), consensus (45c) - TheFly
- 27 days ago - Contineum Therapeutics Reports Second-Quarter 2026 Financial Results; Affirms Key Clinical Development Milestones - Business Wire
- 27 days ago - Contineum Therapeutics Earnings release: Q2 2026 - Filings
- 27 days ago - Contineum Therapeutics Quarterly report: Q2 2026 - Filings
- 2 months ago - Contineum publishes manuscript on PIPE-791 in Journal of Medicinal Chemistry - TheFly
- 2 months ago - Contineum Therapeutics Publishes Discovery of Potential Best-in-Class LPAR1 Antagonist PIPE-791 in Journal of Medicinal Chemistry - Business Wire